Q3 2019 Eagle Pharmaceuticals Inc Earnings Call
Conference Call Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals Inc Conference call or earnings call will be held on Nov 12, 2019 via an 800 number (toll-free). During the earnings conference call's session Eagle Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Eagle Pharmaceuticals Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the United States Food and Drug Administration ("FDA")'s 505(b)(2) New Drug Application ("NDA") regulatory pathway. Our business model is to develop proprietary innovations to FDA-approved, injectable drugs, which we refer to as branded reference drugs, that offer longer commercial duration at attractive prices compared to generic competitors. We market and/or commercialize our products through marketing partners or an external sales force and continue to improve and expand on our internal direct sales force. For each of our current and future pre-commercial products, we intend to enter the market no later than the first generic drug and substantially convert the market by addressing the needs of stakeholders who ultimately use our products.Read more Conference Call